Cholesterol absorption inhibitors (e.g. ezetimibe) and statins are associated with lower risk of liver cancer.
Quoted:
“Use of cholesterol absorption inhibitors was associated with 31% lower odds of liver cancer risk in the overall analysis. These medications were also linked with a lower risk of liver cancer in analyses based on diabetes and liver disease status. The study also confirmed that statins were associated with 35% lower odds of liver cancer.
No associations with liver cancer risk were observed for fibrates, omega-3 fatty acids, or niacin. While bile acid sequestrant use was associated with higher odds of liver cancer risk in the overall analysis, the results of analyses based on diabetes and liver disease status were inconsistent, suggesting that replication of these observations is important.”
medicalxpress.comStatin cholesterol lowering drug linkedmedicalxpress.com#statinsHD #ezetimibeHD #cancerHD #livercancerHD #statinscancerHD #liverHD #statinsliverHD



